Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Kymera Therapeutics Announces Third Quarter 2026 Financial Results and Reports Positive Results from the KT-579 Phase 1 Healthy Volunteer Trial
-
U.S. businesses hedging their bets on North American trade as tariffs and trade disputes show no signs of abating
-
BioCryst to Present New Data for ORLADEYO® (berotralstat) and Navenibart at the 2026 American College of Allergy, Asthma & Immunology Annual Scientific Meeting
-
CytoSorbents to Report Third Quarter 2026 Financial Results and Recent Business Highlights
-
Ligand Reports Third Quarter 2026 Financial Results
-
Aviation Capital Group to Announce Third Quarter 2026 Financial Results on November 10, 2026
-
Glenmark Pharmaceuticals Inaugurates U.S. Distribution Center in Allentown
-
Insmed Reports Third-Quarter 2026 Financial Results and Provides Business Update
-
Radware to Participate in Upcoming Investor Conferences
-
Mintegral Earns Top Global Rankings Across Gaming, Non-Gaming and Creative in AppsFlyer's 2026 Performance Index
-
Ocugen to Participate in Upcoming November Investor and Industry Conferences
-
Hippo Reports Third Quarter 2026 Financial Results
-
First Mid Bancshares, Inc. Announces Third Quarter 2026 Results
-
Keeper Security's Redesigned iOS Vault Features Liquid Glass and iPhone Duo Support
-
Clorox Appoints Fabian Garcia as CEO
-
DFIN Reports Third-Quarter 2026 Results
-
Crocs, Inc. Reports Strong Third Quarter 2026 Results; Raises Full-Year 2026 Outlook
-
MariMed Stockholders Approve Proposed Reverse Stock Split
-
First Northwest Bancorp Reports Third Quarter 2026 Financial Results
-
Recurrent Energy Completes Sale of Two 100 MW / 400 MWh BESS Projects in France to BW ESS
-
Galaxy Applies for National Trust Bank Charter
-
Ocular Therapeutix™ to Participate in November Investor and Scientific Conferences
-
ELIQUENT Life Sciences Joins €13 Million Horizon Europe Consortium to Advance Regulatory Development of Novel Osteoarthritis Therapy
-
Americold Launches Global Innovation Center to Advance Technology, Operations and Customer Solutions
-
Catalyst Bancorp, Inc. Announces 2026 Third Quarter Results
-
AerCap Signs Lease Agreements with Turkish Airlines for Two Boeing 777-300ERSF Converted Aircraft
-
Broadwind Announces Third Quarter 2026 Results Conference Call and Webcast Date
-
Matternet Partners with Swisslog Healthcare's TransLogic to Bring Drone Delivery to Thousands of North American Hospitals
-
Open Enrollment Is Here: What Oklahomans Should Know When Choosing 2027 Health Coverage
-
Hershey Declares Quarterly Dividends
-
SiriusXM Reports Third Quarter 2026 Operating and Financial Results
-
A Father's Search for Answers Leads to Astrosalva Therapeutics, a New Biotech for Alexander Disease and cALD
-
Howmet Aerospace Reports Third Quarter 2026 Results
-
Legence Sets Third Quarter 2026 Earnings Release Date and Webcast Schedule
-
STAAR Surgical Appoints Pascal Aeschlimann as Vice President of Asia Pacific
-
PureTech Founded Entity Celea Therapeutics Appoints Paul Audhya, MD, MBA, as Chief Medical Officer
-
Precision BioSciences to Report Third Quarter 2026 Financial Results on November 3, 2026
-
HCSC Reaffirms Commitment to Individual and Family Markets Across Five States
-
Telesat reports results for the three and nine months ended September 30, 2026
-
NOA Lithium Reports Average Lithium Concentration of 651 Milligrams Per Litre at a Drilled Well at Rio Grande
-
BULGOLD to Present Its Emerging Gold Exploration Story at the Munich Mining Conference
-
Dimensional Fund Advisors Ltd. : Form 8.3 - VESUVIUS PLC - Ordinary Shares
-
DRINKS Launches ANYWHERE Multi-Supplier Network with Cakebread Cellars, PlumpJack Collection of Wineries, and Clif Family Winery
-
Miller Lite Celebrates Historic Brewers™ Win with 'Clinch Cans' Featuring the Actual Beer Being Made the Exact Moment the Team Won It All
-
Open Enrollment Is Here: What Montanans Should Know When Choosing 2027 Health Coverage
-
Joy Organics Wins Three 2026 Healthline Awards
-
Kazia Therapeutics to Participate in Fireside Chat at Guggenheim 3rd Annual Healthcare Innovation Conference
-
Entegris Reports Results for Third Quarter of 2026
-
Eisai to Present New Five-Year Lecanemab Data and Real-World Alzheimer's Disease Research at the 19th Clinical Trials on Alzheimer's Disease (CTAD) Conference
-
Opus Genetics Appoints Dr. Andrew Murphy as Chief Scientific Officer and Jamie Lynne Hart as Executive Director, Executive Operations


